This book is a unique guide to emerging stem cell technologies and the opportunities for their commercialisation. It provides in-depth analyses of the science, business, legal, and financing fundamentals of stem cell technologies, offering a holistic assessment of this emerging and dynamic segment of the field of regenerative medicine.

• Reviews the very latest advances in the technology and business of stem cells used for therapy, research, and diagnostics

• Identifies key challenges to the commercialisation of stem cell technology and avenues to overcome problems in the pipeline

• Written by an expert team with extensive experience in the business, basic and applied science of stem cell research

This comprehensive volume is essential reading for researchers in cell biology, biotechnology, regenerative medicine, and tissue engineering, including scientists and professionals, looking to enter commercial biotechnology fields.

Alain A. Vertès, London Business School, London, UK

Nasib Qureshi, United States Department of Agriculture (ARS), National Center for Agricultural
Utilization Research, Illinois, USA

Arnold I. Caplan, Case Western Reserve University, Ohio, USA

Lee Babiss, Pharmaceutical Product Development, North Carolina, USA